185 related articles for article (PubMed ID: 3736618)
1. Oral-contraceptive use and the risk of breast cancer.
Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
N Engl J Med; 1986 Aug; 315(7):405-11. PubMed ID: 3736618
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and breast cancer.
Brinton LA; Hoover R; Szklo M; Fraumeni JF
Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive agents.
Shearman RP
Med J Aust; 1986 Feb; 144(4):201-5. PubMed ID: 3945219
[TBL] [Abstract][Full Text] [Related]
5. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
6. Oral contraception and breast pathology.
Ragni N; Boccardo E; Viglino S; Larosa E
Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
Collaborative Group on Hormonal Factors in Breast Cancer
Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of the data collection process for a multicenter, population-based, case-control design.
Wingo PA; Ory HW; Layde PM; Lee NC
Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
[TBL] [Abstract][Full Text] [Related]
11. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
12. [Oncological aspects of hormonal contraception].
Bokhman IaV; Korkhov VV; Safronnikova NR
Akush Ginekol (Mosk); 1981 Apr; (4):3-5. PubMed ID: 7018284
[TBL] [Abstract][Full Text] [Related]
13. [Oral contraceptive use and the risk of cancer].
Wingo PA
Fertil Contracept Sex; 1989 Feb; 17(2):125-32. PubMed ID: 12281877
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
Schlesselman JJ; Stadel BV; Murray P; Lai SH
Contraception; 1987 Dec; 36(6):595-613. PubMed ID: 3446437
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
Gwinn ML
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
[TBL] [Abstract][Full Text] [Related]
16. [Syndrome due to estrogen-progestogens in a worker engaged in the production of contraceptive agents].
Gambini G; Farina G; Arbosti G
Med Lav; 1976; 67(2):152-7. PubMed ID: 1021708
[No Abstract] [Full Text] [Related]
17. Neoplasia and hormonal contraception.
Huggins GR
Clin Obstet Gynecol; 1981 Sep; 24(3):903-25. PubMed ID: 7026111
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and breast cancer.
Schlesselman JJ
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1379-87. PubMed ID: 2220962
[TBL] [Abstract][Full Text] [Related]
19. [Lipid metabolism disorders and increased vascular risk due to contraceptive steroids].
Basdevant A; de Lignieres B; Mauvais-Jarvis P
Nouv Presse Med; 1976 Apr; 6(17):1469-72. PubMed ID: 1025526
[No Abstract] [Full Text] [Related]
20. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
Beaumont V; Delplanque B; Lemort N; Beaumont JL
Atherosclerosis; 1982 Sep; 44(3):343-53. PubMed ID: 7150397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
